Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02954900 · ClinicalTrials.gov registry record · NA

Know Your Risk: Assessment at Screening for Breast Cancer - Pilot Study

A NA study of Breast Neoplasms, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT02954900 is a NA study of Breast Neoplasms that has completed, run by Columbia University. The registered enrollment target is 40 participants, below the 569-participant average among 97 other Breast Neoplasms trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02954900, a NA study of Breast Neoplasms, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The purpose of this pilot study is to evaluate a decision support website (RealRisks) designed to inform patients about breast cancer chemoprevention. It is coupled with a physician-centered (BNAV) decision support website as part of clinical workflow in the primary care setting. The investigator hypothesizes that improving accuracy of breast cancer risk perception and understanding of the risks/benefits of chemoprevention will enhance informed decision-making and uptake of breast cancer prevention strategies in the primary care setting.

Conditions Studied

Interventions

  • OTHER RealRisks
  • OTHER BNAV

Study Locations (1)

New York

  • Columbia University Medical Center - New York

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2016-03-15
Est. Completion 2018-10
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT02954900

The ClinicalTrials.gov registry entry for NCT02954900 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 569-participant average among 97 other Breast Neoplasms trials with a reported enrollment target (93% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Neoplasms appearing as the primary indexed condition, and to 2 interventions - of which RealRisks is the first listed.

NCT02954900 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02954900 about?

NCT02954900 is a clinical study titled "Know Your Risk: Assessment at Screening for Breast Cancer - Pilot Study". The purpose of this pilot study is to evaluate a decision support website (RealRisks) designed to inform patients about breast cancer chemoprevention. It is coupled with a physician-centered (BNAV) decision support website as part of clinical workflow in the primary care setting. The investigator hy...

What is the current status of trial NCT02954900?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2016-03-15. Estimated completion is 2018-10.

What conditions does trial NCT02954900 study?

This clinical trial studies the following conditions: Breast Neoplasms.

What interventions are being tested in trial NCT02954900?

The interventions under investigation include: RealRisks (OTHER), BNAV (OTHER).

Who is sponsoring clinical trial NCT02954900?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02954900 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Neoplasms

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.